期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

32例重症药疹回顾性分析 被引量：3

下载PDF
导出
摘要 药品不良反应（adversedrugreaction，ADR）是指合格药品在正常用法、用量下出现的与用药目的无关的非故意导致的有害反应。皮肤是ADR最常见的靶器官之一，药疹是最常见的ADR，其在住院病例中的发生率〉2％。重型史蒂文斯．约翰逊综合征（Steven-Johnson-Syndrome，SJS）及中毒性表皮坏死松解症（TEN），统称SJS—TEN，是一组危及患者生命的重症药疹，死亡率高、危害大，
作者 杨光艳 周小勇 苏飞
机构地区 武汉市第一医院皮肤科
出处 《药物流行病学杂志》 CAS 2013年第11期600-602,共3页 Chinese Journal of Pharmacoepidemiology
关键词 史蒂文斯-约翰逊综合征 中毒性表皮坏死松解症 药疹 回顾性分析
分类号 R758.25 [医药卫生—皮肤病学与性病学]
  • 相关文献

参考文献13

  • 1Fiszenson- Albala F, Auzerie V, Mahe E,et al. A 6- monthprospectivesurvey of cutaneous drug reactions in a hospitalsetting[ J] . Br J Dermatol,2003 ,149( 5) :1018- 1022.
  • 2朱学骏,王宝玺,孙建方,等.皮肤病学[M].第2版,北京:北京大学医学出版社,2011.1476.
  • 3Chave TA,. Mortimer NJ,Sladden MJ,et al. Toxic epider-mal necrolysis : current evidence, practical management andfuture directions [ J ]. The British Journal of Dermatology,2005,153(2) ;241-253.
  • 4Petkov T, Pehlivanov G, Grozdev I,et al. Toxic epidermalnecrolysis as a dermatological manifestation of drug hyper-sensitivity syndrome[ J]. European Journal of Dermatology,2007,17(5) :422427.
  • 5Viard I,Wehrli P,Bullani R, et al. Inhibition of toxic epi-dermal necrolysis by blockade of GD95 with human intrave-nous immunogiobulin[ J]. Science, 1998, 282(5388):490-493.
  • 6Prins C, Kerdel FA, Padilla RS,et al. Treatment of toxicepidermal necrolysis with high-dose intravenous immunoglob-ulins :multicenter retrospective analysis of 48 consecutivecases[ J]. Archives of dermatology,2003, 139(1):26-32.
  • 7Stella M, Clemente A,Bollero D,et al. Toxic epidermalnecrolysis ( TEN) and Stevens-Johnson syndrome ( SJS):experience with high-dose intravenous immunoglobulins andtopical conservative approach. A retrospective analysis [ J }.Journal of International Society for Burn Injuries,2007,33(4) :452-459.
  • 8Mockenhaupt M, Viboud C,Dunant A, et al. Stevens-John-son syndrome and toxic epidermal necrolysis : assessment ofmedication risks with emphasis on recently marketed drugs.The EuroSCAR-study[ J ]. Journal of Investigative Dermatol-ogy, 2008,128(1) :35-44.
  • 9蔡天国,应雪明.别嘌呤醇致重症药疹9例临床分析[J].中国皮肤性病学杂志,2007,21(9):548-549. 被引量：1
  • 10Somkrua R, Eickman EE, Saokaew S, et al. Association ofHLA-B * 5801 allele and allopurinol-induced Stevens Johnsonsyndrome and toxic epidermal necrolysis : a systematic reviewand meta-analysis [ J ]. BMC Medical Genetics, 2011,12:118.

二级参考文献6

  • 1Farquhanson CA,Butler R,Hill A,et al.Allopurinol improves endothelial dysfunction in chronic heart failure[J].Ciculation,2002,106(2):221-226.
  • 2Hamoka H,Mazatani H,Nouchi N,et al.Allopurinol hypersensitivity syndrome hypersensitivity to oxypurinol but not allopurinol[J].Clin EXP Dermatol,1998,23(1):32-34.
  • 3Sullivan JR,Shear NH.The drug hypersensitivity sydrome:What is the pathogenesis?[J].Arch Dermatol,2001,137(3):357-364.
  • 4Hande KR,Noone RM,Stone WJ.Serere allopurinol toxicity.Description and guidelines for prevention in patients with renal insufficiency[J].AMJ.Med,1984,76(1):47-56.
  • 5陈磊,潘萌,郑捷.别嘌呤醇所致各型药疹的预后与肾功能的关系[J].中华皮肤科杂志,2000,33(2):102-103. 被引量：54
  • 6沈新.56例别嘌呤醇药疹的临床特征回顾性分析[J].上海第二医科大学学报,2002,22(3):288-288. 被引量：13

共引文献6

同被引文献39

  • 1黄玉斌.381例别嘌醇不良反应分析[J].中国药物应用与监测,2005,2(1):32-34. 被引量：23
  • 2宋薇,刘精东.高尿酸血症和痛风的流行病学及影响因素研究进展[J].江西医药,2013,48(5):459-462. 被引量：49
  • 3干皆诚,庄宣,姚志荣,张定国.47例别嘌呤醇药疹临床及预后分析[J].皮肤病与性病,2007,29(3):6-7. 被引量：3
  • 4ROUJEAU J C, STERN R S. Severe adverse cutaneous reactions to drugs [J]. N Engl J Med, 1994,331 ( 19) : 1272- 1285.
  • 5SOMKRUA R, EICKMAN E E, SAOKAE S, et al. Association of HLA-B * 5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis . a systematic review and Meta-analysis [J] . BMC Med Genet, 2011 ,12: 118-127.
  • 6GERULL R, NELLE M, SCHAIBLE T. Toxic epidermal necrolysis and Stevens-Johnson: a review [J]. Crit Care Med,2011 ,39(6) :1521-1532.
  • 7ARELLANO F, SACRISTAN J A. Allopurinol hypersensitivity syndrome: a review [J] . Ann Pharmacother, 1993 , 27(3) :337-343.
  • 8ROUJEAU J C. Clinical heterogeneity of drug hypersensitivity[J]. Toxicology ,2005,209(2) : 123-129.
  • 9HUNG S I, CHUNG W H, LIOU L B, et al. HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [J]. Proc Natl Acad Sci USA,2005 ,102(11) :4134-4139.
  • 10TASSANEEYAKUL W,JANTARAROUNGTONG T,CHEN P, et al. Strong association between HLA-B * 5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population [J]. Pharmacogenet Genomics, 2009 , 19 ( 9) : 704 - 709.

引证文献3

二级引证文献3

药物流行病学杂志
2013年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部